Last reviewed · How we verify

NCT03726580

Evaluation of Neurotoxic Effect of Sevoflurane-Based AnaesthesiaGuided by Short-Term Olfactory Identification

Completed Last updated 1 November 2018
What this trial tests

trial testing Sevoflurane in Neurotoxic Effect of Sevoflurane-Based Anaesthesia in 600 participants. Completed in 1 October 2018.

Timeline
1 March 2017
Primary endpoint
1 September 2018
1 October 2018

Quick facts

Lead sponsorTanta University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment600
Start date1 March 2017
Primary completion1 September 2018
Estimated completion1 October 2018
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

Adults 60 to 75, any sex, with Neurotoxic Effect of Sevoflurane-Based Anaesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nowadays there is increasing doubts about the safety of anesthesia . Anesthesiologists have to console the worried patients, who are anxious about the potential risks of anesthetic-induced brain damage, by suggesting that any detrimental effects would be "mild".Anesthetics are responsible for postoperative taste and odor defects and cognitive dysfunction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Sevoflurane

Trials testing the same drug.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03726580.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing